Physician profile
Joshua Levy
NPI 1821191750
$3,028.44
in general payments reported to CMS, 2019-2025
19 companies · $380 in 2025
The $380 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.83 · 2020: $411 · 2021: $256 · 2022: $290 · 2023: $451 · 2024: $1,141 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,973.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,972.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,767.82 | 2019-2025 | Enbrel, Otezla, Tavneos |
| Glaxosmithkline, LLC. | $237.30 | 2019-2025 | Benlysta |
| Novartis Pharmaceuticals Corporation | $210.43 | 2024-2025 | |
| Ucb, INC. | $141.57 | 2024 | Cimzia |
| Boston Scientific Corporation | $125.85 | 2020 | |
| Abbvie INC. | $91.99 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $67.46 | 2023-2024 | Opsumit |
| Ani Pharmaceuticals, INC. | $65.50 | 2024 | Purified Cortrophin Gel |
| Genentech USA, INC. | $49.95 | 2021 | |
| Shield Therapeutics INC | $49.38 | 2025 | |
| Alkermes, INC. | $42.54 | 2020 | |
| Tonix Medicines, INC. | $38.20 | 2025 | Tonmya |
| Radius Health, INC. | $31.60 | 2024 | |
| Aurinia Pharma U.S., INC. | $29.66 | 2025 | Lupkynis |
| Regeneron Healthcare Solutions, INC. | $28.14 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $14.64 | 2025 | |
| Celgene Corporation | $12.62 | 2019 | |
| Lilly USA, LLC | $12.43 | 2019 | |
| Janssen Biotech, INC. | $11.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.